欢迎访问浙江中西医结合杂志   今天是   加入收藏   |   设为首页
许瞻,谷红苹,倪约翰,应华娜.社区获得性肺炎(痰热壅肺证)中医临床路径的药物经济学研究[J].浙江中西医结合杂志,2019,29(2):
社区获得性肺炎(痰热壅肺证)中医临床路径的药物经济学研究
Pharmacoeconomics evaluation of TCM clinical pathway on Community-acquired pneumonia patients of Lung Phlegm-Heat Syndrome
投稿时间:2018-04-20  修订日期:2018-08-02
DOI:
中文关键词:  中医临床路径  社区获得性肺炎  随机对照研究  成本分析
英文关键词:TCM clinical pathway  Community-acquired pneumonia  randomized controlled trial  Cost analysis
基金项目:余姚市科技计划项目:社区获得性肺炎中医临床路径的药物经济学评价(2017YYB02)
作者单位E-mail
许瞻 余姚中医医院 浙江余姚 315400 xss197910aaa@sina.com 
谷红苹* 余姚中医医院 浙江余姚 315400 guzi1982@126.com 
倪约翰 余姚中医医院 浙江余姚 315400  
应华娜 余姚中医医院 浙江余姚 315400  
摘要点击次数: 709
全文下载次数: 2
中文摘要:
      目的:非重症社区获得性肺炎(CAP)中医临床路径的有效性及经济性。方法:将219例CAP患者(痰热壅肺证)随机分组,结果:剔除11例,对照组69例,观察1组69例,观察2组70例。三组均严格执行临床路径方案,对照组单用西药治疗。观察1组在对照组基础上加用中药汤剂,观察2组在观察1组基础上加用穴位贴敷。结果:采用中医证候疗效评估:三组愈显率比较,对照组60.87%,观察1组76.81%,观察2组84.29%,两组观察组疗效显著(与对照组比较,均P<0.05)。采用药物经济学评价方法:住院总成本与中草药、中医治疗费无相关性(P>0.05); 观察2组西药成本及综合服务成本明显减少(P<0.05)。结论:中医药治疗手段治疗社区获得性肺炎可缓解临床证候,减少住院天数,减少住院总成本。社区获得性肺炎中医临床路径的实施具有可行性、有效性、经济性。
英文摘要:
      Objective: To observe the effects and economical efficiency of TCM clinical pathway on community-acquired pneumonia(CAP) patients. Methods: 219 patients with CAP of Lung Phlegm-Heat syndrome were randomly divided into three groups with 11 cases were excluded, 69 cases in control group, 69 cases in experimental group 1, and 70 cases in experimental group 2. Control group strictly implemented clinical pathway plan, and the patients were only treated with western medicine. Experimental group 1 patients were added with Chinese medicine decoction on the basis of control group, and experimental group 2 patients were additionally treated with Acupoint Application on the basis of experimental group 1. Results:There was significiant difference in the markedly effective rate: control group (60.87%), experimental group 1 (76.81%), experimental group 2(84.29%) (P<0.05). The total cost of hospitalization was not related to the cost of Chinese herbal medicine and Chinese medicine treatment by adopting pharmacoeconomic evaluation method (P>0.05). The cost of Western medicine and comprehensive service in group C were significantly reduced (P<0.05). Conclusion: TCM treatment of CAP can alleviate clinical syndromes, reduce hospitalization days, and reduce total hospitalization costs. TCM clinical pathway was aviable,effective and econominal therapy for CAP.
查看全文  查看/发表评论  下载PDF阅读器
关闭